These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 12433703

  • 1. Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene.
    van Gils CH, Bostick RM, Stern MC, Taylor JA.
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1279-84. PubMed ID: 12433703
    [Abstract] [Full Text] [Related]

  • 2. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ.
    Cancer Res; 1999 Mar 15; 59(6):1225-30. PubMed ID: 10096552
    [Abstract] [Full Text] [Related]

  • 3. Lycopene intake and prostate cancer risk: effect modification by plasma antioxidants and the XRCC1 genotype.
    Goodman M, Bostick RM, Ward KC, Terry PD, van Gils CH, Taylor JA, Mandel JS.
    Nutr Cancer; 2006 Mar 15; 55(1):13-20. PubMed ID: 16965236
    [Abstract] [Full Text] [Related]

  • 4. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk.
    Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA.
    Cancer Epidemiol Biomarkers Prev; 2001 Feb 15; 10(2):125-31. PubMed ID: 11219769
    [Abstract] [Full Text] [Related]

  • 5. XRCC1 and XRCC3 polymorphisms and their role as effect modifiers of unsaturated fatty acids and antioxidant intake on colorectal adenomas risk.
    Stern MC, Siegmund KD, Corral R, Haile RW.
    Cancer Epidemiol Biomarkers Prev; 2005 Mar 15; 14(3):609-15. PubMed ID: 15767338
    [Abstract] [Full Text] [Related]

  • 6. XRCC1 polymorphism and lung cancer risk.
    Schneider J, Classen V, Helmig S.
    Expert Rev Mol Diagn; 2008 Nov 15; 8(6):761-80. PubMed ID: 18999926
    [Abstract] [Full Text] [Related]

  • 7. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
    Shu XO, Cai Q, Gao YT, Wen W, Jin F, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 15; 12(12):1462-7. PubMed ID: 14693738
    [Abstract] [Full Text] [Related]

  • 8. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
    Shen M, Hung RJ, Brennan P, Malaveille C, Donato F, Placidi D, Carta A, Hautefeuille A, Boffetta P, Porru S.
    Cancer Epidemiol Biomarkers Prev; 2003 Nov 15; 12(11 Pt 1):1234-40. PubMed ID: 14652287
    [Abstract] [Full Text] [Related]

  • 9. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV, Calle EE, Pavluck AL, Feigelson HS, Thun MJ, Rodriguez C.
    Breast Cancer Res; 2005 Nov 15; 7(6):R1168-73. PubMed ID: 16457697
    [Abstract] [Full Text] [Related]

  • 10. Gene-environment interactions between the codon 194 polymorphism of XRCC1 and antioxidants influence lung cancer risk.
    Ratnasinghe DL, Yao SX, Forman M, Qiao YL, Andersen MR, Giffen CA, Erozan Y, Tockman MS, Taylor PR.
    Anticancer Res; 2003 Nov 15; 23(1B):627-32. PubMed ID: 12680158
    [Abstract] [Full Text] [Related]

  • 11. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk.
    Ito H, Matsuo K, Hamajima N, Mitsudomi T, Sugiura T, Saito T, Yasue T, Lee KM, Kang D, Yoo KY, Sato S, Ueda R, Tajima K.
    Carcinogenesis; 2004 Aug 15; 25(8):1395-401. PubMed ID: 15044328
    [Abstract] [Full Text] [Related]

  • 12. Genetic variants of DNA repair genes and prostate cancer: a population-based study.
    Ritchey JD, Huang WY, Chokkalingam AP, Gao YT, Deng J, Levine P, Stanczyk FZ, Hsing AW.
    Cancer Epidemiol Biomarkers Prev; 2005 Jul 15; 14(7):1703-9. PubMed ID: 16030105
    [Abstract] [Full Text] [Related]

  • 13. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW, Chen C, Chokkalingam AP, Gao YT, Dightman DA, Nguyen HT, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, Reichardt JK.
    Cancer Epidemiol Biomarkers Prev; 2001 Oct 15; 10(10):1077-82. PubMed ID: 11588134
    [Abstract] [Full Text] [Related]

  • 14. Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer.
    Chacko P, Rajan B, Joseph T, Mathew BS, Pillai MR.
    Breast Cancer Res Treat; 2005 Jan 15; 89(1):15-21. PubMed ID: 15666192
    [Abstract] [Full Text] [Related]

  • 15. DNA-repair genetic polymorphisms and breast cancer risk.
    Smith TR, Levine EA, Perrier ND, Miller MS, Freimanis RI, Lohman K, Case LD, Xu J, Mohrenweiser HW, Hu JJ.
    Cancer Epidemiol Biomarkers Prev; 2003 Nov 15; 12(11 Pt 1):1200-4. PubMed ID: 14652281
    [Abstract] [Full Text] [Related]

  • 16. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review.
    Hung RJ, Hall J, Brennan P, Boffetta P.
    Am J Epidemiol; 2005 Nov 15; 162(10):925-42. PubMed ID: 16221808
    [Abstract] [Full Text] [Related]

  • 17. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.
    Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC.
    Cancer Epidemiol Biomarkers Prev; 2003 Apr 15; 12(4):359-65. PubMed ID: 12692111
    [Abstract] [Full Text] [Related]

  • 18. Polymorphisms of DNA base-excision repair genes APE/Ref-1 and XRCC1 are not associated with the risk for Graves' disease.
    Doğru-Abbasoğlu S, Tanrikulu S, Ademoğlu E, Erbil Y, Ozderya A, Karadağ B, Uysal M.
    Cell Biochem Funct; 2009 Oct 15; 27(7):462-7. PubMed ID: 19711438
    [Abstract] [Full Text] [Related]

  • 19. Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia.
    Pakakasama S, Sirirat T, Kanchanachumpol S, Udomsubpayakul U, Mahasirimongkol S, Kitpoka P, Thithapandha A, Hongeng S.
    Pediatr Blood Cancer; 2007 Jan 15; 48(1):16-20. PubMed ID: 16435384
    [Abstract] [Full Text] [Related]

  • 20. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J, Classen V, Bernges U, Philipp M.
    Int J Mol Med; 2005 Oct 15; 16(4):709-16. PubMed ID: 16142409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.